Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Hemodialysis Patients

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.net/journal/ijcm
E-mail: [email protected]

Citations

"Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Hemodialysis Patients"
written by Ayaka Saito, Takako Onuki, Yoshihisa Echida, Shigeru Otsubo, Kosaku Nitta,
published by International Journal of Clinical Medicine, Vol.5 No.17, 2014

has been cited by the following article(s):

[1]	Silencing Survivin: a Key Therapeutic Strategy for Cardiac Hypertrophy
	Journal of …, 2022

[2]	Iron Indices and Mortality in Maintenance Hemodialysis Patients
	2018

[3]	Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease
	2018

[1]	Silencing Survivin: a Key Therapeutic Strategy for Cardiac Hypertrophy Journal of Cardiovascular Translational Research, 2022 DOI:10.1007/s12265-021-10165-1

[2]	Iron Indices and Mortality in Maintenance Hemodialysis Patients International Journal of Clinical Medicine, 2018 DOI:10.4236/ijcm.2018.95039

[3]	Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease Renal Replacement Therapy, 2018 DOI:10.1186/s41100-018-0172-9